Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Social Influencers: The Role of Social Determinants of Health in Injured Worker Recovery

Gaining visibility into Social Determinants of Health that intersect with workplace injury and recovery
Summer 2022

Giving Notice: How Workforce Attrition Impacts Workers’ Comp

Millions of workers are changing occupations, leading to ripple effects for comp.
Summer 2022

State of the States

A roundup of regulatory activity around the country
Summer 2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

WCRI Reports on the Pandemic’s Impact on Medical Utilization

Despite decreases in injury frequency across all groups, younger workers still saw higher use of emergency departments.
Mar 2025

Psilocybin and Ketamine Therapy Bills Introduced Across the Country

So far, seven psilocybin therapy bills have been introduced in 2025, with three ketamine therapy bills.
Mar 2025

Healthesystems Announces Key Promotion to Support Innovation in Data Analytics

Mike Theis has been promoted to AVP, Product Analytics and Business Strategy
Mar 2025

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Saliva Test with At-Home Collection Authorized

Saliva samples collected at-home must be sent to the designated lab.
May 2020

Remdesivir a Potential Treatment for COVID-19?

The FDA allows emergency use in response to positive trials, but more research is needed.
May 2020
1 … 14 15 16 17 18 … 28

Whitepapers

lockmap-markermagnifiercrossmenucross-circle